Hanson & Doremus Investment Management - SUNESIS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 44 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Hanson & Doremus Investment Management ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$0
-100.0%
1660.0%0.00%–
Q4 2017$1,000–1660.0%0.00%–
Q3 2017$0–1660.0%0.00%–
Q2 2017$0
-100.0%
1660.0%0.00%–
Q1 2017$1,000
-99.8%
1660.0%0.00%–
Q4 2016$601,000–166–0.00%–
 Download
Other shareholders

There were no reported owners of SUNESIS PHARMACEUTICALS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of SUNESIS PHARMACEUTICALS INC shareholders